Yuki Tsushima

Title: Yuki Tsushima: Innovator in Modified Release Formulations

Introduction

Yuki Tsushima is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of modified release formulations. With a total of five patents to his name, Tsushima's work has the potential to impact the treatment of various diseases and disorders.

Latest Patents

Tsushima's latest patents focus on modified release compositions in solid oral dosage forms. These compositions comprise amisulpride, presented as an unequal mixture of (R)-amisulpride and (S)-amisulpride, or their pharmaceutically acceptable salts. Notably, the amount of (R)-amisulpride exceeds that of (S)-amisulpride. The patents also detail medicaments that utilize these formulations for treating a range of diseases and disorders, including specific dosage regimens. Additionally, the patents explore formulations that employ polymorphs of enantiomeric amisulpride.

Career Highlights

Throughout his career, Yuki Tsushima has worked with notable companies in the pharmaceutical industry, including Sunovion Pharmaceuticals Inc. and Takeda Pharmaceutical Company Limited. His experience in these organizations has contributed to his expertise in drug formulation and development.

Collaborations

Tsushima has collaborated with several professionals in his field, including Takumi Asada and Gerald R Galluppi. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in pharmaceutical formulations.

Conclusion

Yuki Tsushima's contributions to modified release formulations demonstrate his commitment to advancing pharmaceutical science. His innovative work continues to pave the way for improved treatment options for patients worldwide.